Company profile
Aptose Biosciences, Inc.
Precision Oncology for Therapies of Tomorrow
- Industry
- Biotechnology Research
- Employees
- 29
- Headquarters
- San Diego, California
- Founded
- 2014
- LinkedIn followers
- 3,571
- Office locations
- 2
Aptose Biosciences, Inc. company summary
Aptose Biosciences, Inc. is a company in the Biotechnology Research industry, headquartered in San Diego, California, founded in 2014. On LinkedIn the company has around 29 employees and 3,571 followers. The company lists 2 office locations. Its listed specialties include Oncology, Myelodysplastic Syndromes, Acute Myeloid Leukemia, Hematology, Drug Development & Discovery.
What technology does Aptose Biosciences, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Aptose Biosciences, Inc.
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies. CG-806, our oral mutation-agnostic FLT3/BTK inhibitor, is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. CG-806 is also being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML), including the emerging populations resistant to approved targeted therapies. APTO-253, our first-in-class MYC Inhibitor, is being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Specialties
Where is Aptose Biosciences, Inc. located?
Aptose Biosciences, Inc. lists 2 office locations.
Compare companies similar to Aptose Biosciences, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Aptose Biosciences, Inc. aptose.com | Biotechnology Research | 29 | 2014 | San Diego, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Aptose Biosciences, Inc.
What does Aptose Biosciences, Inc. do?
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies. CG-806, our oral mutation-agnostic FLT3/BTK inhibitor, is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. CG-806 is also being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML), including the emerging populations resistant to approved targeted therapies. APTO-253, our first-in-class MYC Inhibitor, is being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
How many employees does Aptose Biosciences, Inc. have?
Aptose Biosciences, Inc. has around 29 employees on LinkedIn.
Where is Aptose Biosciences, Inc. headquartered?
Aptose Biosciences, Inc. is headquartered in San Diego, California.
Where does Aptose Biosciences, Inc. have offices?
Aptose Biosciences, Inc. lists 2 office locations, including San Diego, California, US; Mississauga, Ontario L4V 1R9, CA.
When was Aptose Biosciences, Inc. founded?
Aptose Biosciences, Inc. was founded in 2014.
Build a lead list from companies like Aptose Biosciences, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.